-       Report 
   - February 2025
    -  175 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                  -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €2937EUR$3,273USD£2,577GBP 
      €3455EUR$3,850USD£3,032GBP 
                -       Report 
   - July 2025
    -  325 Pages 
    Global
   
   From       €4442EUR$4,950USD£3,898GBP 
                -       Report 
   - August 2025
    -  200 Pages 
    Global
   
   From       €2234EUR$2,490USD£1,961GBP 
                -       Report 
   - March 2025
    -  173 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                 -       Report 
   - November 2025
    -  95 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - November 2025
    -  201 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - May 2025
    -  120 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - February 2025
    -  211 Pages 
    Global
   
   From       €2243EUR$2,500USD£1,969GBP 
                  -       Report 
   - March 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
      €4352EUR$4,850USD£3,820GBP 
                -       Report 
   - August 2025
    -  154 Pages 
    Global
   
   From       €3230EUR$3,599USD£2,834GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4441EUR$4,949USD£3,898GBP 
                -       Report 
   - January 2025
    -  143 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3455EUR$3,850USD£3,032GBP 
                -       Report 
   - July 2025
    -  265 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                -       Report 
   - April 2025
    -  100 Pages 
    United States
   
   From       €3544EUR$3,950USD£3,111GBP 
                -       Report 
   - June 2025
    -  200 Pages 
    United States
   
   From       €2234EUR$2,490USD£1,961GBP 
                -       Directory 
   - January 2025
    -  80 Pages 
    Global
   
             -       Report 
   - July 2025
    -  90 Pages 
    Australia
   
   From       €3141EUR$3,500USD£2,756GBP 
                -       Report 
   - January 2024
    -  125 Pages 
    Global
   
   From       €5339EUR$5,950USD£4,686GBP 
             
         The recreational cannabis market has become a notable segment within the broader analgesics industry, as consumers increasingly seek alternatives to traditional over-the-counter and prescription pain relievers. Cannabis is touted for its pain-relieving properties, with THC and CBD being the most prominent constituents associated with analgesic effects. Recreational cannabis offers a dual benefit of alleviating pain and providing a pleasurable experience, which has led to its rising popularity where    it is legally permitted. It is available in various forms, including but not limited to flower, edibles, oils, and topicals. Consumers can choose products based on desired effect, potency, and mode of consumption. The market's expansion is further driven by ongoing research and development aimed at understanding the therapeutic potential of cannabis and optimizing its use for pain management. 
Several companies have established their presence in the recreational cannabis market with a focus on analgesic products. Well-known players include Canopy Growth Corporation, Aurora Cannabis, and Tilray, all of which have extensive product lines and international reach. Other notable companies are Curaleaf and Cresco Labs, which have a strong presence in the United States. These companies are engaged in competitive strategies, including product innovation and mergers & acquisitions, to capture a larger share of the market. Show Less   Read more